APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Idiopathic Constipation Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chronic Idiopathic Constipation Drugs Market Analysis and Forecast 2026-2032

20 December 2025204 pages

Choose your research edition.

Industry ResearchChronic Idiopathic Constipation Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Idiopathic Constipation Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Chronic Idiopathic Constipation Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Idiopathic Constipation Drugs Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Idiopathic Constipation Drugs Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Chronic Idiopathic Constipation Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Chronic Idiopathic Constipation Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chronic Idiopathic Constipation Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chronic Idiopathic Constipation Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chronic Idiopathic Constipation Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Chronic Idiopathic Constipation Drugs include Sanofi, Merck, Eli Lilly, Pfizer, Glaxosmithkline, Bayer AG, Theravance Biopharma Inc, Synergy Pharmaceuticals and Sucampo Pharmaceuticals Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Chronic Idiopathic Constipation Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chronic Idiopathic Constipation Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Chronic Idiopathic Constipation Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chronic Idiopathic Constipation Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chronic Idiopathic Constipation Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Chronic Idiopathic Constipation Drugs sales, projected growth trends, production technology, application and end-user industry.

Chronic Idiopathic Constipation Drugs Segment by Company

Sanofi

Merck

Eli Lilly

Pfizer

Glaxosmithkline

Bayer AG

Theravance Biopharma Inc

Synergy Pharmaceuticals

Sucampo Pharmaceuticals Inc

Salix Pharmaceuticals Ltd

Roche Holding AG

Progenics Pharmaceuticals Inc

Ironwood Pharmaceuticals Inc

Ferring International Center S.A

Daiichi Sankyo

Cosmo Pharmaceuticals SA

Chugai Pharmaceutical

Bausch Health

Allergens

Chronic Idiopathic Constipation Drugs Segment by Type

Linaclotide

Lubiprostone

Others

Chronic Idiopathic Constipation Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Chronic Idiopathic Constipation Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Idiopathic Constipation Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Idiopathic Constipation Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Idiopathic Constipation Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Chronic Idiopathic Constipation Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Chronic Idiopathic Constipation Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Idiopathic Constipation Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chronic Idiopathic Constipation Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Linaclotide Major Manufacturers Table 3. Lubiprostone Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Chronic Idiopathic Constipation Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Retail Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Hospital Pharmacies Major Manufacturers Table 9. Chronic Idiopathic Constipation Drugs Industry Trends Table 10. Chronic Idiopathic Constipation Drugs Industry Drivers Table 11. Chronic Idiopathic Constipation Drugs Industry Opportunities and Challenges Table 12. Chronic Idiopathic Constipation Drugs Industry Restraints Table 13. Global Chronic Idiopathic Constipation Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Chronic Idiopathic Constipation Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Chronic Idiopathic Constipation Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Chronic Idiopathic Constipation Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Chronic Idiopathic Constipation Drugs Sales by Region (2021-2026) & (K Units) Table 20. Global Chronic Idiopathic Constipation Drugs Sales by Region (2027-2032) & (K Units) Table 21. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Region (2021-2026) Table 22. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Region (2027-2032) Table 23. Global Chronic Idiopathic Constipation Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Chronic Idiopathic Constipation Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Chronic Idiopathic Constipation Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Chronic Idiopathic Constipation Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Chronic Idiopathic Constipation Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Chronic Idiopathic Constipation Drugs Manufacturers, Product Type & Application Table 31. Global Chronic Idiopathic Constipation Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Chronic Idiopathic Constipation Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Chronic Idiopathic Constipation Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Chronic Idiopathic Constipation Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Chronic Idiopathic Constipation Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 41. Global Chronic Idiopathic Constipation Drugs Sales by Type (2027-2032) & (K Units) Table 42. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Type (2021-2026) Table 43. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Type (2027-2032) Table 44. Global Chronic Idiopathic Constipation Drugs Price by Type (2021-2026) & (US$/Unit) Table 45. Global Chronic Idiopathic Constipation Drugs Price by Type (2027-2032) & (US$/Unit) Table 46. Global Chronic Idiopathic Constipation Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Chronic Idiopathic Constipation Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Chronic Idiopathic Constipation Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Chronic Idiopathic Constipation Drugs Sales by Application (2027-2032) & (K Units) Table 54. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Application (2021-2026) Table 55. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Application (2027-2032) Table 56. Global Chronic Idiopathic Constipation Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Chronic Idiopathic Constipation Drugs Price by Application (2027-2032) & (US$/Unit) Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Sanofi Chronic Idiopathic Constipation Drugs Product Portfolio Table 62. Sanofi Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Merck Chronic Idiopathic Constipation Drugs Product Portfolio Table 67. Merck Recent Development Table 68. Eli Lilly Company Information Table 69. Eli Lilly Business Overview Table 70. Eli Lilly Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Eli Lilly Chronic Idiopathic Constipation Drugs Product Portfolio Table 72. Eli Lilly Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Pfizer Chronic Idiopathic Constipation Drugs Product Portfolio Table 77. Pfizer Recent Development Table 78. Glaxosmithkline Company Information Table 79. Glaxosmithkline Business Overview Table 80. Glaxosmithkline Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Glaxosmithkline Chronic Idiopathic Constipation Drugs Product Portfolio Table 82. Glaxosmithkline Recent Development Table 83. Bayer AG Company Information Table 84. Bayer AG Business Overview Table 85. Bayer AG Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bayer AG Chronic Idiopathic Constipation Drugs Product Portfolio Table 87. Bayer AG Recent Development Table 88. Theravance Biopharma Inc Company Information Table 89. Theravance Biopharma Inc Business Overview Table 90. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Product Portfolio Table 92. Theravance Biopharma Inc Recent Development Table 93. Synergy Pharmaceuticals Company Information Table 94. Synergy Pharmaceuticals Business Overview Table 95. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Product Portfolio Table 97. Synergy Pharmaceuticals Recent Development Table 98. Sucampo Pharmaceuticals Inc Company Information Table 99. Sucampo Pharmaceuticals Inc Business Overview Table 100. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio Table 102. Sucampo Pharmaceuticals Inc Recent Development Table 103. Salix Pharmaceuticals Ltd Company Information Table 104. Salix Pharmaceuticals Ltd Business Overview Table 105. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Product Portfolio Table 107. Salix Pharmaceuticals Ltd Recent Development Table 108. Roche Holding AG Company Information Table 109. Roche Holding AG Business Overview Table 110. Roche Holding AG Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Roche Holding AG Chronic Idiopathic Constipation Drugs Product Portfolio Table 112. Roche Holding AG Recent Development Table 113. Progenics Pharmaceuticals Inc Company Information Table 114. Progenics Pharmaceuticals Inc Business Overview Table 115. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio Table 117. Progenics Pharmaceuticals Inc Recent Development Table 118. Ironwood Pharmaceuticals Inc Company Information Table 119. Ironwood Pharmaceuticals Inc Business Overview Table 120. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio Table 122. Ironwood Pharmaceuticals Inc Recent Development Table 123. Ferring International Center S.A Company Information Table 124. Ferring International Center S.A Business Overview Table 125. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Product Portfolio Table 127. Ferring International Center S.A Recent Development Table 128. Daiichi Sankyo Company Information Table 129. Daiichi Sankyo Business Overview Table 130. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Product Portfolio Table 132. Daiichi Sankyo Recent Development Table 133. Cosmo Pharmaceuticals SA Company Information Table 134. Cosmo Pharmaceuticals SA Business Overview Table 135. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Product Portfolio Table 137. Cosmo Pharmaceuticals SA Recent Development Table 138. Chugai Pharmaceutical Company Information Table 139. Chugai Pharmaceutical Business Overview Table 140. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Product Portfolio Table 142. Chugai Pharmaceutical Recent Development Table 143. Bausch Health Company Information Table 144. Bausch Health Business Overview Table 145. Bausch Health Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Bausch Health Chronic Idiopathic Constipation Drugs Product Portfolio Table 147. Bausch Health Recent Development Table 148. Allergens Company Information Table 149. Allergens Business Overview Table 150. Allergens Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Allergens Chronic Idiopathic Constipation Drugs Product Portfolio Table 152. Allergens Recent Development Table 153. North America Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2026) & (US$ Million) Table 154. North America Chronic Idiopathic Constipation Drugs Revenue by Type (2027-2032) & (US$ Million) Table 155. North America Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 156. North America Chronic Idiopathic Constipation Drugs Sales by Type (2027-2032) & (K Units) Table 157. North America Chronic Idiopathic Constipation Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 158. North America Chronic Idiopathic Constipation Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 159. North America Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2026) & (US$ Million) Table 160. North America Chronic Idiopathic Constipation Drugs Revenue by Application (2027-2032) & (US$ Million) Table 161. North America Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 162. North America Chronic Idiopathic Constipation Drugs Sales by Application (2027-2032) & (K Units) Table 163. North America Chronic Idiopathic Constipation Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 164. North America Chronic Idiopathic Constipation Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 165. North America Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. North America Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. North America Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. North America Chronic Idiopathic Constipation Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 169. North America Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026) & (K Units) Table 170. North America Chronic Idiopathic Constipation Drugs Sales by Country (2027-2032) & (K Units) Table 171. North America Chronic Idiopathic Constipation Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 172. North America Chronic Idiopathic Constipation Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 173. United States Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 174. Canada Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 175. Europe Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2026) & (US$ Million) Table 176. Europe Chronic Idiopathic Constipation Drugs Revenue by Type (2027-2032) & (US$ Million) Table 177. Europe Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 178. Europe Chronic Idiopathic Constipation Drugs Sales by Type (2027-2032) & (K Units) Table 179. Europe Chronic Idiopathic Constipation Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 180. Europe Chronic Idiopathic Constipation Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 181. Europe Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2026) & (US$ Million) Table 182. Europe Chronic Idiopathic Constipation Drugs Revenue by Application (2027-2032) & (US$ Million) Table 183. Europe Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 184. Europe Chronic Idiopathic Constipation Drugs Sales by Application (2027-2032) & (K Units) Table 185. Europe Chronic Idiopathic Constipation Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 186. Europe Chronic Idiopathic Constipation Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 187. Europe Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. Europe Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. Europe Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. Europe Chronic Idiopathic Constipation Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 191. Europe Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026) & (K Units) Table 192. Europe Chronic Idiopathic Constipation Drugs Sales by Country (2027-2032) & (K Units) Table 193. Europe Chronic Idiopathic Constipation Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 194. Europe Chronic Idiopathic Constipation Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 195. Germany Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 196. France Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 197. U.K. Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 198. Italy Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 199. Netherlands Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 200. Nordic Countries Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 201. China Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2026) & (US$ Million) Table 202. China Chronic Idiopathic Constipation Drugs Revenue by Type (2027-2032) & (US$ Million) Table 203. China Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 204. China Chronic Idiopathic Constipation Drugs Sales by Type (2027-2032) & (K Units) Table 205. China Chronic Idiopathic Constipation Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 206. China Chronic Idiopathic Constipation Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 207. China Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2026) & (US$ Million) Table 208. China Chronic Idiopathic Constipation Drugs Revenue by Application (2027-2032) & (US$ Million) Table 209. China Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 210. China Chronic Idiopathic Constipation Drugs Sales by Application (2027-2032) & (K Units) Table 211. China Chronic Idiopathic Constipation Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 212. China Chronic Idiopathic Constipation Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 213. Asia Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2026) & (US$ Million) Table 214. Asia Chronic Idiopathic Constipation Drugs Revenue by Type (2027-2032) & (US$ Million) Table 215. Asia Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 216. Asia Chronic Idiopathic Constipation Drugs Sales by Type (2027-2032) & (K Units) Table 217. Asia Chronic Idiopathic Constipation Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 218. Asia Chronic Idiopathic Constipation Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 219. Asia Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2026) & (US$ Million) Table 220. Asia Chronic Idiopathic Constipation Drugs Revenue by Application (2027-2032) & (US$ Million) Table 221. Asia Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 222. Asia Chronic Idiopathic Constipation Drugs Sales by Application (2027-2032) & (K Units) Table 223. Asia Chronic Idiopathic Constipation Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 224. Asia Chronic Idiopathic Constipation Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 225. Asia Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. Asia Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. Asia Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. Asia Chronic Idiopathic Constipation Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 229. Asia Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026) & (K Units) Table 230. Asia Chronic Idiopathic Constipation Drugs Sales by Country (2027-2032) & (K Units) Table 231. Asia Chronic Idiopathic Constipation Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 232. Asia Chronic Idiopathic Constipation Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 233. Japan Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 234. South Korea Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 235. India Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 236. Australia Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 237. China Taiwan Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 238. Southeast Asia Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 239. SAMEA Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2026) & (US$ Million) Table 240. SAMEA Chronic Idiopathic Constipation Drugs Revenue by Type (2027-2032) & (US$ Million) Table 241. SAMEA Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 242. SAMEA Chronic Idiopathic Constipation Drugs Sales by Type (2027-2032) & (K Units) Table 243. SAMEA Chronic Idiopathic Constipation Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 244. SAMEA Chronic Idiopathic Constipation Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 245. SAMEA Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2026) & (US$ Million) Table 246. SAMEA Chronic Idiopathic Constipation Drugs Revenue by Application (2027-2032) & (US$ Million) Table 247. SAMEA Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 248. SAMEA Chronic Idiopathic Constipation Drugs Sales by Application (2027-2032) & (K Units) Table 249. SAMEA Chronic Idiopathic Constipation Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 250. SAMEA Chronic Idiopathic Constipation Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 251. SAMEA Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 252. SAMEA Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 253. SAMEA Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 254. SAMEA Chronic Idiopathic Constipation Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 255. SAMEA Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026) & (K Units) Table 256. SAMEA Chronic Idiopathic Constipation Drugs Sales by Country (2027-2032) & (K Units) Table 257. SAMEA Chronic Idiopathic Constipation Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 258. SAMEA Chronic Idiopathic Constipation Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 259. Brazil Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 260. Argentina Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 261. Chile Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 262. Colombia Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 263. Peru Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 264. Saudi Arabia Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 265. Israel Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 266. UAE Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 267. Turkey Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 268. Iran Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 269. Egypt Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Table 270. Key Raw Materials Table 271. Raw Materials Key Suppliers Table 272. Chronic Idiopathic Constipation Drugs Distributors List Table 273. Chronic Idiopathic Constipation Drugs Customers List Table 274. Research Programs/Design for This Report Table 275. Authors List of This Report Table 276. Secondary Sources Table 277. Primary Sources List of Figures Figure 1. Chronic Idiopathic Constipation Drugs Image Figure 2. Global Chronic Idiopathic Constipation Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Idiopathic Constipation Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Linaclotide Image Figure 5. Lubiprostone Image Figure 6. Others Image Figure 7. Global Chronic Idiopathic Constipation Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Chronic Idiopathic Constipation Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Retail Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Hospital Pharmacies Image Figure 12. Global Chronic Idiopathic Constipation Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Chronic Idiopathic Constipation Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Chronic Idiopathic Constipation Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Chronic Idiopathic Constipation Drugs Sales (2021-2032) & (K Units) Figure 18. Global Chronic Idiopathic Constipation Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Chronic Idiopathic Constipation Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Europe Chronic Idiopathic Constipation Drugs Sales YoY (2021-2032) & (K Units) Figure 22. China Chronic Idiopathic Constipation Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Chronic Idiopathic Constipation Drugs Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Chronic Idiopathic Constipation Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Global Chronic Idiopathic Constipation Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Chronic Idiopathic Constipation Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Chronic Idiopathic Constipation Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Chronic Idiopathic Constipation Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Chronic Idiopathic Constipation Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Chronic Idiopathic Constipation Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Chronic Idiopathic Constipation Drugs Revenue Share by Type (2021-2032) Figure 41. North America Chronic Idiopathic Constipation Drugs Sales Share by Type (2021-2032) Figure 42. North America Chronic Idiopathic Constipation Drugs Revenue Share by Application (2021-2032) Figure 43. North America Chronic Idiopathic Constipation Drugs Sales Share by Application (2021-2032) Figure 44. North America Chronic Idiopathic Constipation Drugs Revenue Share by Country (2021-2032) Figure 45. North America Chronic Idiopathic Constipation Drugs Sales Share by Country (2021-2032) Figure 46. Europe Chronic Idiopathic Constipation Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Chronic Idiopathic Constipation Drugs Sales Share by Type (2021-2032) Figure 48. Europe Chronic Idiopathic Constipation Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Chronic Idiopathic Constipation Drugs Sales Share by Application (2021-2032) Figure 50. Europe Chronic Idiopathic Constipation Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Chronic Idiopathic Constipation Drugs Sales Share by Country (2021-2032) Figure 52. China Chronic Idiopathic Constipation Drugs Revenue Share by Type (2021-2032) Figure 53. China Chronic Idiopathic Constipation Drugs Sales Share by Type (2021-2032) Figure 54. China Chronic Idiopathic Constipation Drugs Revenue Share by Application (2021-2032) Figure 55. China Chronic Idiopathic Constipation Drugs Sales Share by Application (2021-2032) Figure 56. Asia Chronic Idiopathic Constipation Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Chronic Idiopathic Constipation Drugs Sales Share by Type (2021-2032) Figure 58. Asia Chronic Idiopathic Constipation Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Chronic Idiopathic Constipation Drugs Sales Share by Application (2021-2032) Figure 60. Asia Chronic Idiopathic Constipation Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Chronic Idiopathic Constipation Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Chronic Idiopathic Constipation Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Chronic Idiopathic Constipation Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Chronic Idiopathic Constipation Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Chronic Idiopathic Constipation Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Chronic Idiopathic Constipation Drugs Revenue Share by Country (2021-2032)

Scope & coverage.

Types
  • Linaclotide
  • Lubiprostone
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Sanofi
  • Merck
  • Eli Lilly
  • Pfizer
  • Glaxosmithkline
  • Bayer AG
  • Theravance Biopharma Inc
  • Synergy Pharmaceuticals
  • Sucampo Pharmaceuticals Inc
  • Salix Pharmaceuticals Ltd
  • Roche Holding AG
  • Progenics Pharmaceuticals Inc
  • Ironwood Pharmaceuticals Inc
  • Ferring International Center S.A
  • Daiichi Sankyo
  • Cosmo Pharmaceuticals SA
  • Chugai Pharmaceutical
  • Bausch Health
  • Allergens

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chronic Idiopathic Constipation Drugs Market by Type
  3. 1.2.1 Global Chronic Idiopathic Constipation Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Linaclotide
  5. 1.2.3 Lubiprostone
  6. 1.2.4 Others
  7. 1.3 Chronic Idiopathic Constipation Drugs Market by Application
  8. 1.3.1 Global Chronic Idiopathic Constipation Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Retail Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Hospital Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Chronic Idiopathic Constipation Drugs Market Dynamics
  1. 2.1 Chronic Idiopathic Constipation Drugs Industry Trends
  2. 2.2 Chronic Idiopathic Constipation Drugs Industry Drivers
  3. 2.3 Chronic Idiopathic Constipation Drugs Industry Opportunities and Challenges
  4. 2.4 Chronic Idiopathic Constipation Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Chronic Idiopathic Constipation Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Chronic Idiopathic Constipation Drugs Revenue by Region
  3. 3.2.1 Global Chronic Idiopathic Constipation Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chronic Idiopathic Constipation Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Chronic Idiopathic Constipation Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Chronic Idiopathic Constipation Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Chronic Idiopathic Constipation Drugs Sales by Region
  9. 3.4.1 Global Chronic Idiopathic Constipation Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Chronic Idiopathic Constipation Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Chronic Idiopathic Constipation Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Chronic Idiopathic Constipation Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Chronic Idiopathic Constipation Drugs Revenue by Manufacturers
  2. 4.1.1 Global Chronic Idiopathic Constipation Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Chronic Idiopathic Constipation Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chronic Idiopathic Constipation Drugs Sales by Manufacturers
  6. 4.2.1 Global Chronic Idiopathic Constipation Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Chronic Idiopathic Constipation Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Chronic Idiopathic Constipation Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Chronic Idiopathic Constipation Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Chronic Idiopathic Constipation Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Chronic Idiopathic Constipation Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Chronic Idiopathic Constipation Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Chronic Idiopathic Constipation Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Chronic Idiopathic Constipation Drugs Market CR5 and HHI
  16. 4.8.2 2025 Chronic Idiopathic Constipation Drugs Tier 1, Tier 2, and Tier 3
5 Chronic Idiopathic Constipation Drugs Market by Type
  1. 5.1 Global Chronic Idiopathic Constipation Drugs Revenue by Type
  2. 5.1.1 Global Chronic Idiopathic Constipation Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Chronic Idiopathic Constipation Drugs Sales by Type
  6. 5.2.1 Global Chronic Idiopathic Constipation Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chronic Idiopathic Constipation Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Chronic Idiopathic Constipation Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Chronic Idiopathic Constipation Drugs Price by Type
6 Chronic Idiopathic Constipation Drugs Market by Application
  1. 6.1 Global Chronic Idiopathic Constipation Drugs Revenue by Application
  2. 6.1.1 Global Chronic Idiopathic Constipation Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Chronic Idiopathic Constipation Drugs Sales by Application
  6. 6.2.1 Global Chronic Idiopathic Constipation Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Chronic Idiopathic Constipation Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Chronic Idiopathic Constipation Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Chronic Idiopathic Constipation Drugs Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Chronic Idiopathic Constipation Drugs Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Chronic Idiopathic Constipation Drugs Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Chronic Idiopathic Constipation Drugs Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Chronic Idiopathic Constipation Drugs Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 Glaxosmithkline
  26. 7.5.1 Glaxosmithkline Company Information
  27. 7.5.2 Glaxosmithkline Business Overview
  28. 7.5.3 Glaxosmithkline Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Glaxosmithkline Chronic Idiopathic Constipation Drugs Product Portfolio
  30. 7.5.5 Glaxosmithkline Recent Developments
  31. 7.6 Bayer AG
  32. 7.6.1 Bayer AG Company Information
  33. 7.6.2 Bayer AG Business Overview
  34. 7.6.3 Bayer AG Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bayer AG Chronic Idiopathic Constipation Drugs Product Portfolio
  36. 7.6.5 Bayer AG Recent Developments
  37. 7.7 Theravance Biopharma Inc
  38. 7.7.1 Theravance Biopharma Inc Company Information
  39. 7.7.2 Theravance Biopharma Inc Business Overview
  40. 7.7.3 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Product Portfolio
  42. 7.7.5 Theravance Biopharma Inc Recent Developments
  43. 7.8 Synergy Pharmaceuticals
  44. 7.8.1 Synergy Pharmaceuticals Company Information
  45. 7.8.2 Synergy Pharmaceuticals Business Overview
  46. 7.8.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Product Portfolio
  48. 7.8.5 Synergy Pharmaceuticals Recent Developments
  49. 7.9 Sucampo Pharmaceuticals Inc
  50. 7.9.1 Sucampo Pharmaceuticals Inc Company Information
  51. 7.9.2 Sucampo Pharmaceuticals Inc Business Overview
  52. 7.9.3 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio
  54. 7.9.5 Sucampo Pharmaceuticals Inc Recent Developments
  55. 7.10 Salix Pharmaceuticals Ltd
  56. 7.10.1 Salix Pharmaceuticals Ltd Company Information
  57. 7.10.2 Salix Pharmaceuticals Ltd Business Overview
  58. 7.10.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Product Portfolio
  60. 7.10.5 Salix Pharmaceuticals Ltd Recent Developments
  61. 7.11 Roche Holding AG
  62. 7.11.1 Roche Holding AG Company Information
  63. 7.11.2 Roche Holding AG Business Overview
  64. 7.11.3 Roche Holding AG Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Roche Holding AG Chronic Idiopathic Constipation Drugs Product Portfolio
  66. 7.11.5 Roche Holding AG Recent Developments
  67. 7.12 Progenics Pharmaceuticals Inc
  68. 7.12.1 Progenics Pharmaceuticals Inc Company Information
  69. 7.12.2 Progenics Pharmaceuticals Inc Business Overview
  70. 7.12.3 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio
  72. 7.12.5 Progenics Pharmaceuticals Inc Recent Developments
  73. 7.13 Ironwood Pharmaceuticals Inc
  74. 7.13.1 Ironwood Pharmaceuticals Inc Company Information
  75. 7.13.2 Ironwood Pharmaceuticals Inc Business Overview
  76. 7.13.3 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio
  78. 7.13.5 Ironwood Pharmaceuticals Inc Recent Developments
  79. 7.14 Ferring International Center S.A
  80. 7.14.1 Ferring International Center S.A Company Information
  81. 7.14.2 Ferring International Center S.A Business Overview
  82. 7.14.3 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Product Portfolio
  84. 7.14.5 Ferring International Center S.A Recent Developments
  85. 7.15 Daiichi Sankyo
  86. 7.15.1 Daiichi Sankyo Company Information
  87. 7.15.2 Daiichi Sankyo Business Overview
  88. 7.15.3 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Product Portfolio
  90. 7.15.5 Daiichi Sankyo Recent Developments
  91. 7.16 Cosmo Pharmaceuticals SA
  92. 7.16.1 Cosmo Pharmaceuticals SA Company Information
  93. 7.16.2 Cosmo Pharmaceuticals SA Business Overview
  94. 7.16.3 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Product Portfolio
  96. 7.16.5 Cosmo Pharmaceuticals SA Recent Developments
  97. 7.17 Chugai Pharmaceutical
  98. 7.17.1 Chugai Pharmaceutical Company Information
  99. 7.17.2 Chugai Pharmaceutical Business Overview
  100. 7.17.3 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Product Portfolio
  102. 7.17.5 Chugai Pharmaceutical Recent Developments
  103. 7.18 Bausch Health
  104. 7.18.1 Bausch Health Company Information
  105. 7.18.2 Bausch Health Business Overview
  106. 7.18.3 Bausch Health Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Bausch Health Chronic Idiopathic Constipation Drugs Product Portfolio
  108. 7.18.5 Bausch Health Recent Developments
  109. 7.19 Allergens
  110. 7.19.1 Allergens Company Information
  111. 7.19.2 Allergens Business Overview
  112. 7.19.3 Allergens Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Allergens Chronic Idiopathic Constipation Drugs Product Portfolio
  114. 7.19.5 Allergens Recent Developments
8 North America
  1. 8.1 North America Chronic Idiopathic Constipation Drugs Market Size by Type
  2. 8.1.1 North America Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Chronic Idiopathic Constipation Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Chronic Idiopathic Constipation Drugs Price by Type (2021-2032)
  5. 8.2 North America Chronic Idiopathic Constipation Drugs Market Size by Application
  6. 8.2.1 North America Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Chronic Idiopathic Constipation Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Chronic Idiopathic Constipation Drugs Price by Application (2021-2032)
  9. 8.3 North America Chronic Idiopathic Constipation Drugs Market Size by Country
  10. 8.3.1 North America Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Chronic Idiopathic Constipation Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Chronic Idiopathic Constipation Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Chronic Idiopathic Constipation Drugs Market Size by Type
  2. 9.1.1 Europe Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Chronic Idiopathic Constipation Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Chronic Idiopathic Constipation Drugs Price by Type (2021-2032)
  5. 9.2 Europe Chronic Idiopathic Constipation Drugs Market Size by Application
  6. 9.2.1 Europe Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Chronic Idiopathic Constipation Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Chronic Idiopathic Constipation Drugs Price by Application (2021-2032)
  9. 9.3 Europe Chronic Idiopathic Constipation Drugs Market Size by Country
  10. 9.3.1 Europe Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Chronic Idiopathic Constipation Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Chronic Idiopathic Constipation Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Chronic Idiopathic Constipation Drugs Market Size by Type
  2. 10.1.1 China Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Chronic Idiopathic Constipation Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Chronic Idiopathic Constipation Drugs Price by Type (2021-2032)
  5. 10.2 China Chronic Idiopathic Constipation Drugs Market Size by Application
  6. 10.2.1 China Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Chronic Idiopathic Constipation Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Chronic Idiopathic Constipation Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chronic Idiopathic Constipation Drugs Market Size by Type
  2. 11.1.1 Asia Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Chronic Idiopathic Constipation Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Chronic Idiopathic Constipation Drugs Price by Type (2021-2032)
  5. 11.2 Asia Chronic Idiopathic Constipation Drugs Market Size by Application
  6. 11.2.1 Asia Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Chronic Idiopathic Constipation Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Chronic Idiopathic Constipation Drugs Price by Application (2021-2032)
  9. 11.3 Asia Chronic Idiopathic Constipation Drugs Market Size by Country
  10. 11.3.1 Asia Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Chronic Idiopathic Constipation Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Chronic Idiopathic Constipation Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chronic Idiopathic Constipation Drugs Market Size by Type
  2. 12.1.1 SAMEA Chronic Idiopathic Constipation Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Chronic Idiopathic Constipation Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Chronic Idiopathic Constipation Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Chronic Idiopathic Constipation Drugs Market Size by Application
  6. 12.2.1 SAMEA Chronic Idiopathic Constipation Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Chronic Idiopathic Constipation Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Chronic Idiopathic Constipation Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Chronic Idiopathic Constipation Drugs Market Size by Country
  10. 12.3.1 SAMEA Chronic Idiopathic Constipation Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Chronic Idiopathic Constipation Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Chronic Idiopathic Constipation Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Chronic Idiopathic Constipation Drugs Value Chain Analysis
  2. 13.1.1 Chronic Idiopathic Constipation Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Chronic Idiopathic Constipation Drugs Production Mode & Process
  6. 13.2 Chronic Idiopathic Constipation Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Chronic Idiopathic Constipation Drugs Distributors
  9. 13.2.3 Chronic Idiopathic Constipation Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst